A historical and molecular phylogeny of BCG strains

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 915-922

  Behr, M A ^a   Small, P M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BCG; DNA fingerprinting; Tuberculosis

Indexed keywords

BCG VACCINE; LIVE VACCINE;

ARTICLE; BCG VACCINATION; DNA FINGERPRINTING; GENETIC VARIABILITY; HISTORY OF MEDICINE; MYCOBACTERIUM BOVIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; VACCINE PRODUCTION;

EID: 0033605241     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00277-1     Document Type: Review

References (55)

1. Fine P.E.M. Bacille Calmette-Guérin vaccines: A rough guide. Clin. Infect. Dis. 20:1995;11-14.
2. Comstock G.W. Field trials of tuberculosis vaccines: how could we have done them better? Control. Clin. Trials. 15:1994;247-276.
3. Colditz G.A., Brewer T.F., Berkley C.S., Wilson M.E., Burdick E., Fineberg H.V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 271:1994;698-702.
4. Malin A.S., Young D.B. Designing a vaccine for tuberculosis. Br. Med. J. 312:1996;1495.
5. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1996;1274-1282.
6. Collins D.M., De Lisle G.W. BCG identification by DNA restriction fragment patterns. J. Gen. Microbiol. 133:1987;1431-1434.
7. Fomukong N.G., Dale J.W., Osborn T.W., Grange J.M. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J. Appl. Bacteriol. 72:1992;126-133.
8. Harboe M., Nagai S. MPB70, a unique antigen of Mycobacterium bovis BCG. Am. Rev. Respir. Dis. 129:1984;444-452.
9. Minnikin D.E., Parlett J.H., Magnusson M., Ridell M., Lind A. Mycolic acid patterns of representatives of Mycobacterium bovis BCG. J. Gen. Microbiol. 130:1984;2733-2736.
10. Bolanos O. Variations in the virulence of BCG. Acta. Tuberc. Scand. 22:1948;125-133.
11. Dubos R.J., Pierce C.H. Differential characteristics in vitro and in vivo of several substrains of BCG. Am. Rev. Tuberc. 74:1956;655-717.
12. Ladefoged A., Bunch-Christensen K., Guld J. The protective effect in bank voles of some strains of BCG. Bull. World. Health. Organ. 43:1970;71-90.
13. Frappier A, Portelance V, St-Pierre J, Panisset M. BCG Strains: Characteristics and Relative Efficacy. In: Barclay WR, Koch-Weser D, Wolinsky E, Chamberlayne EC, editors. Status of Immunization in Tuberculosis in 1971, Fogarty International Center Proceedings No. 14. Washington, DHEW Publication, 1971. p. 157-178.
14. Lagranderie M.R., Balazuc A., Deriaud E., Leclerc C.D., Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect. Immun. 64:1996;1-9.
15. ten Dam HG. BCG Vaccination. In: Reichman LB, Hershfield ES, editors. Tuberculosis A Comprehensive International Approach. Dekker, New York, 1993. p. 251-274.
16. Frappier A, Panisset M. La Souche du BCG. Institut de Microbiologie et d'Hygiene de l'Université de Montréal, Montréal, P.Q., Canada, 1957.
17. Perkins F.T. Analysis of the replies to a questionnaire. Symp. Ser. Immunobiol. Stand. 17:1971;5-40.
18. Georghiu M. Institut Pasteur. personal communication.
19. Talbot E.A., Williams D.L., Frothingham R. PCR identification of Mycobacterium bovis BCG. J. Clin. Microbiol. 35:1997;566-569.
20. Ulstrup J.C., Jeansson S., Wiker H.G., Harboe M. Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination. Infect. Immum. 63:1995;672-675.
21. van Soolingen D., Hermans P.W., de Haas P.E., Soll D.R., van Embden J.D. The occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains; evaluation of insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:1991;2578-2586.
22. vansoolingen D., Hermans P.W.M., de Haas P.E.W., van Embden J.D. Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J. Clin. Microbiol. 30:1992;1772-1777.
23. van Embden J.D., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D., Gicquel B., Hermans P.W., Martin C., McAdam R.A., Shinnick T.M., Small P.M. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:1993;406-409.
24. Chaves F., Yang Z., El-Hajj H., Alonso M., Burman W.J., Eisenach K.D., Dronda F., Bates J.H., Cave M.D. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J. Clin. Microbiol. 34:1996;1118-1123.
25. Howard S.T., Laszlo A., Johnson W.M. Genetic identification of Mycobacterium bovis BCG by restriction fragment length polymorphism analysis of the Direct-Repeat region. J. Clin. Microbiol. 35:1997;965-968.
26. Calmette A., Guérin C., Breton M. Contribution à l'étude de la tuberculose expérimentale du cobaye. Ann. Inst. Pasteur. 21:1907;401-416.
27. Calmette A., Guérin C. Recherches expérimentales sur la défense de l'organisme contre l'infection tuberculeuse. Ann. Inst. Pasteur. 25:1911;625-641.
28. Guérin C, Rosenthal SR. The history of BCG: early history. In: Rosenthal SR, editors. BCG Vaccination Against Tuberculosis. London, J&H Churchill, 1957. p. 48-57.
29. Calmette A., Guérin C. Nouvelles recherches expérimentales sur la vaccination des bovidés contre la tuberculose. Ann. Inst. Pasteur. 34:1920;553-560.
30. Calmette A. Preventive vaccination against tuberculosis with BCG. Proc. Royal Soc. Med. 24:1931;85-94.
31. Sakula A. BCG: who were Calmette and Guérin? Thorax. 38:1983;806-812.
32. Obayashi Y. Dried BCG Vaccine. Geneva, World Health Organization, 1955. p. 7-29.
33. Wallgren A. Intradermal vaccinations with BCG virus. JAMA. 91:1928;1876-1881.
34. Lind A. The Swedish strain of BCG. Tubercle. 64:1983;233-234.
35. Aronson J.D., Dannenberg A.M. Effect of vaccination with BCG on tuberculosis in infancy and childhood. Am. J. Dis. Child. 50:1935;1117-1130.
36. Birkhaug K. BCG vaccination in Scandinavia. Am. Rev. Tuberc. 55:1947;234-249.
37. Jensen K.A. Practice of the Calmette vaccination. Acta. Tuberc. Scand. 20:1946;1-45.
38. National Jewish Hospital Research Center. Mycobacterial Culture Collection. NIH Publication No. 80-289, 1980.
39. Birkhaug K. Virulence and tuberculogenic studies of sixty consecutive weekly lots of BCG vaccine produced by standard technique. Am. Rev. Tuberc. 59:1949;567-588.
40. Stainer D.W., Landi S. Stability of BCG vaccines. Devel. Biol. Stand. 58:1986;119-125.
41. Osborn T.W. Serial subcultivation of Czechoslovakian and Japanese BCG strains. J. Hyg. 85:1980;235-247.
42. Osborn T.W. Changes in BCG strains. Tubercle. 64:1983;1-13.
43. Gheorghiu M., Augier J., Lagrange P.H. Maintenance and control of the French BCG strain 1173-P2 (primary and secondary seed-lots). Bull. Inst. Pasteur. 81:1983;281-288.
44. Behr M.A., Small P.M. Has BCG attenuated to impotence? Nature. 389:1997;133-134.
45. Aronson J.D., Parr E.I., Saylor R.M. BCG vaccine. Its preparation and the local reaction to its injection. Am. Rev. Tuberc. 42:1940;651-666.
46. Crispen R. History of BCG and its substrains. Prog. Clin. Biol. Res. 310:1989;35-50.
47. Dale J. personal communication.
48. Petroff S.A. A New analysis of the value and safety of protective immunization with BCG (Bacillus Calmette-Guérin). Am. Rev. Tuberc. 20:1929;275-296.
49. Dreyer G., Vollum R.L. Mutation and pathogenicity experiments with BCG. Lancet. 1:1931;9-14.
50. Boquet A. Sur les propriétés pathogènes du BCG. Ann. Inst. Pasteur. 47:(2):1931;117-134.
51. Frimodt-Moller J. Dissociation of Tubercle Bacilli. Lewis, London, 1939. p. 117.
52. Kayne G.G. BCG vaccination in Western Europe. Am. Rev. Tuberc. 34:1936;10-42.
53. Zeyland J., Piasecka-Zeyland E. Sur la vitalité du BCG dans l'organisme vacciné Ann. Inst. Pasteur. 56:1936;46-51.
54. Streng K.O. Etude des caractères d'atennuation du bacille BCG suivant le nombre de passages de ce germe sur pomme de terre à la bile de boeuf. Ann. Inst. Pasteur. 64:1940;196-202.
55. Nègre L. Preface. In: Frappier A, Panisset M, editors. La Souche du BCG. l'Institut de Microbiologie et d'Hygiene de l'Université de Montréal, Montréal, PQ, Canada, 1957. p. 7-9.